A detailed history of Pro Share Advisors LLC transactions in Repligen Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 2,451 shares of RGEN stock, worth $351,056. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,451
Previous 2,533 3.24%
Holding current value
$351,056
Previous $465,000 33.76%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$120.0 - $182.95 $9,840 - $15,001
-82 Reduced 3.24%
2,451 $308,000
Q1 2024

May 08, 2024

SELL
$170.78 - $208.42 $33,814 - $41,267
-198 Reduced 7.25%
2,533 $465,000
Q4 2023

Feb 14, 2024

SELL
$114.17 - $185.35 $7,991 - $12,974
-70 Reduced 2.5%
2,731 $491,000
Q3 2023

Nov 13, 2023

SELL
$138.78 - $176.51 $31,086 - $39,538
-224 Reduced 7.4%
2,801 $445,000
Q2 2023

Aug 10, 2023

SELL
$138.42 - $180.31 $6,505 - $8,474
-47 Reduced 1.53%
3,025 $427,000
Q1 2023

May 11, 2023

SELL
$154.26 - $198.1 $137,754 - $176,903
-893 Reduced 22.52%
3,072 $517,000
Q4 2022

Feb 02, 2023

BUY
$162.42 - $220.56 $52,136 - $70,799
321 Added 8.81%
3,965 $671,000
Q3 2022

Nov 04, 2022

SELL
$160.42 - $256.21 $5,454 - $8,711
-34 Reduced 0.92%
3,644 $682,000
Q2 2022

Aug 01, 2022

SELL
$140.68 - $188.02 $202,579 - $270,748
-1,440 Reduced 28.14%
3,678 $597,000
Q1 2022

May 10, 2022

SELL
$161.19 - $257.96 $131,047 - $209,721
-813 Reduced 13.71%
5,118 $962,000
Q4 2021

Feb 08, 2022

BUY
$247.59 - $304.47 $294,632 - $362,319
1,190 Added 25.1%
5,931 $1.57 Million
Q3 2021

Nov 12, 2021

SELL
$194.77 - $324.21 $187,173 - $311,565
-961 Reduced 16.85%
4,741 $1.37 Million
Q2 2021

Aug 13, 2021

BUY
$165.87 - $220.95 $137,008 - $182,504
826 Added 16.94%
5,702 $1.14 Million
Q1 2021

May 14, 2021

BUY
$180.37 - $226.26 $5,411 - $6,787
30 Added 0.62%
4,876 $948,000
Q4 2020

Feb 09, 2021

BUY
$148.08 - $206.57 $104,692 - $146,044
707 Added 17.08%
4,846 $929,000
Q3 2020

Nov 13, 2020

BUY
$122.51 - $158.27 $32,342 - $41,783
264 Added 6.81%
4,139 $611,000
Q2 2020

Aug 03, 2020

SELL
$94.33 - $140.48 $164,039 - $244,294
-1,739 Reduced 30.98%
3,875 $479,000
Q1 2020

May 15, 2020

SELL
$84.96 - $109.14 $557,507 - $716,176
-6,562 Reduced 53.89%
5,614 $542,000
Q4 2019

Feb 12, 2020

BUY
$73.84 - $93.08 $125,749 - $158,515
1,703 Added 16.26%
12,176 $1.13 Million
Q3 2019

Nov 12, 2019

BUY
$76.65 - $95.51 $393,137 - $489,870
5,129 Added 95.98%
10,473 $803,000
Q2 2019

Aug 13, 2019

SELL
$54.2 - $85.95 $1,571 - $2,492
-29 Reduced 0.54%
5,344 $459,000
Q1 2019

May 15, 2019

BUY
$49.45 - $62.8 $8,060 - $10,236
163 Added 3.13%
5,373 $317,000
Q4 2018

Feb 14, 2019

SELL
$48.26 - $68.88 $889,045 - $1.27 Million
-18,422 Reduced 77.95%
5,210 $275,000
Q3 2018

Nov 14, 2018

SELL
$46.8 - $58.97 $51,058 - $64,336
-1,091 Reduced 4.41%
23,632 $1.31 Million
Q2 2018

Aug 13, 2018

SELL
$35.26 - $47.04 $49,152 - $65,573
-1,394 Reduced 5.34%
24,723 $1.16 Million
Q1 2018

May 14, 2018

SELL
$30.92 - $37.27 $125,813 - $151,651
-4,069 Reduced 13.48%
26,117 $945,000
Q4 2017

Feb 14, 2018

BUY
$32.53 - $38.92 $189,845 - $227,137
5,836 Added 23.97%
30,186 $1.1 Million
Q3 2017

Nov 13, 2017

BUY
$36.98 - $46.06 $121,220 - $150,984
3,278 Added 15.56%
24,350 $933,000
Q2 2017

Aug 11, 2017

BUY
N/A
21,072
21,072 $873,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.95B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.